Eisai Joins WIPO Sponsored Global Consortium for Neglected Tropical Disease Research and Development

October 26, 2011, Tokyo, Japan -- Eisai Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito, ("Eisai") announced today that it has joined WIPO Re:Search, a new global consortium established on October 26 (local time in Geneva, Switzerland) and sponsored by the World Intellectual Property Organization (WIPO) with the aim of supporting research and development for neglected tropical diseases. Eisai is the only Japanese pharmaceutical company to become a member of the consortium.

Click here to view the entire press release.

Type Press Release

Date Released October 26, 2011

RECENT RELEASES
Apr 11, 2021

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced that its animation “Leave No One Behind-Disease of Neglected People” which features activities for the...

Mar 31, 2021

Eisai Inc. announced today the launch of Spot Her—an initiative to end the silence around endometrial cancer, a type of uterine cancer, and inspire women to listen, advocate and put their health...

Mar 19, 2021

KENILWORTH, N.J., and WOODCLIFF LAKE, N.J., March 19, 2021 – Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Eisai today announced the first presentation of...

Alerts - Release page
SUBSCRIBE TO OUR NEWS
* Required Fields